Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Revacept in symptomatic carotid stenosis
NCT01645306Phase 2Completed
- Sponsor
- AdvanceCOR
- Start
- Mar 2013
- Primary completion
- Oct 2018
- Modality
- Fc-Fusion Proteins
- Countries
- 2
01
Overview
A Phase 2 trial of revacept in carotid artery stenosis (CAS), sponsored by AdvanceCOR. Started Mar 2013; status: completed.
02
Drugs
revacept
03
Conditions
carotid artery stenosis (CAS)
Beyond the preview
Go deeper on NCT01645306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01645306.